XARELTO®: Chronic coronary artery disease and peripheral artery disease treatment

XARELTO® 2.5 mg VASCULAR DOSE*:Significantly reduced a composite of cv death, mi, and stroke† in combination with aspirin in patients with chronic CAD or PAD1

* XARELTO® 2.5 mg twice daily with aspirin 100 mg once daily.

Major cardiovascular events were a composite of cardiovascular death, myocardial infarction, or stroke.

CAD = coronary artery disease; CV = cardiovascular; MI = myocardial infarction; PAD = peripheral artery disease.